Join
Live feed
·
INSIDERFilingvia Quantisnow
Keros Therapeutics Inc. logo

Chief Legal Officer Cho Esther sold $46,151 worth of shares (4,485 units at $10.29), decreasing direct ownership by 11% to 35,770 units (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
KROS· Keros Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KROS (Keros Therapeutics Inc.) and more on Quantisnow.

Chief Legal Officer Cho Esther sold $46,151 worth of shares (4,485 units at $10.29), decreasing direct ownership by 11% to 35,770 units (SEC Form 4) to satisfy tax liability | Quantisnow